Delivery Order SPE2DB24D2100-SPE2DB25FBGKS
- Not listed
- The Defense Logistics Agency awarded a $1,966.20 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Junel FE 1 mg-20 mcg tablets in 28-count packaging. This firm fixed price delivery order, with an ultimate completion date of July 22, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $2,178.02 to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count) on March 12, 2025, with an ultimate completion date of March 13, 2025. This is a firm fixed-price, non-set-aside contract for delivery to the company's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,650.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) on September 16, 2025, with completion scheduled for September 17, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $2,727.12 to AmerisourceBergen Drug Corp for Junel Fe 1.5 mg-30 mcg tablets (28-count packaging) on September 9, 2025, with completion expected by September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,800.03 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) on September 8, 2025, with completion expected by September 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is classified as a child contract under a larger vehicle. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,084.18 to AmerisourceBergen Drug Corp for the supply of Junel Fe 1.5 mg-30 mcg tablets in quantities of 28, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The pharmaceutical product is a common oral contraceptive combining norethindrone and...
- The Defense Logistics Agency awarded a delivery order valued at $2,587.38 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) on August 11, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by August 12, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader relationship with the federal government for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,437.99 for Junel FE 1 mg-20 mcg tablets (28-count), a hormonal contraceptive medication. The contract was competitively awarded without set-aside designation on September 3, 2025, with an ultimate completion date of September 4, 2025. Performance will be executed from the company's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.54 to AmerisourceBergen Drug Corp for the supply of Junel FE 1.5 mg-30 mcg tablets in a 28-count package. This competitively awarded, firm fixed-price contract was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,558.38 to AmerisourceBergen Drug Corp for the supply of Junel Fe 1 mg-20 mcg tablets (28-count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a child delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGKSDelivery Order
This delivery order, valued at $1,587.03, was awarded on September 16, 2025, to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packaging). The Defense Logistics Agency, under the Department of Defense, funded this competitively awarded contract with no set-aside designation. Performance will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order represents a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant role in the Defense Logistics Agency's medical supply chain. The broader IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities to support military healthcare programs globally. This particular delivery order for oral contraceptive tablets reflects the company's ongoing support of military healthcare requirements through the DLA's pharmaceutical procurement programs, which serve the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/16/25 |